| Bioactivity | Protein Kinase C (19-36) is a pseudosubstrate peptide inhibitor of protein kinase C (PKC), with an IC50 of 0.18 μM. Protein Kinase C (19-36) markedly attenuated vascular hyperproliferation and hypertrophy as well as glucose-induced suppression of natriuretic peptide receptor response[1]. | ||||||
| Name | Protein Kinase C (19-36) | ||||||
| CAS | 113731-96-7 | ||||||
| Sequence | Arg-PheAla-Arg-Lys-Gly-Ala-Leu-Arg-Gln-Lys-Asn-Val-His-Glu-Val-Lys-Asn | ||||||
| Shortening | RFARKGALRQKNVHEVKN | ||||||
| Formula | C93H159N35O24 | ||||||
| Molar Mass | 2151.48 | ||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||
| Storage | Sealed storage, away from moisture and light, under nitrogen
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light, under nitrogen) |
Protein Kinase C (19-36)
CAS: 113731-96-7 F: C93H159N35O24 W: 2151.48
Protein Kinase C (19-36) is a pseudosubstrate peptide inhibitor of protein kinase C (PKC), with an IC50 of 0.18 μM. Pro
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.